Solbach Thomas F, König Jörg, Fromm Martin F, Zolk Oliver
Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Trends Cardiovasc Med. 2006 Jan;16(1):7-15. doi: 10.1016/j.tcm.2005.10.001.
Members of the ATP-binding cassette (ABC) protein superfamily are integral membrane proteins involved in energy-dependent transport of a wide variety of substrates across biologic membranes. ATP-binding cassette transporters serve as functional barriers against the entry of xenobiotics, for example, in the intestine or at the blood-brain barrier, or contribute to drug excretion, for example, in the kidney or the liver. Many human ABC transporters, such as ABCB1 (P-glycoprotein), ABCC5 (MRP5), or ABCC9 (SUR2), are expressed in the heart, suggesting an important role of these transporters in cardiac drug effects or physiology. Interestingly, mutations in ABCC9, a constituent of cardiac K(ATP) channels, can cause dilated cardiomyopathy in humans, providing evidence that dysfunction of cardiac ABC transporters might have clinical implications. This review aims to give insights into the possible functions of ABC transporters in the heart, their role in drug disposition, as well as control of intracellular cyclic nucleotide levels or regulation of K(ATP) channel conductivity.
ATP结合盒(ABC)蛋白超家族的成员是整合膜蛋白,参与多种底物跨生物膜的能量依赖性转运。例如,在肠道或血脑屏障中,ATP结合盒转运蛋白作为对外源物质进入的功能性屏障,或者在肾脏或肝脏中,有助于药物排泄。许多人类ABC转运蛋白,如ABCB1(P-糖蛋白)、ABCC5(MRP5)或ABCC9(SUR2),在心脏中表达,表明这些转运蛋白在心脏药物效应或生理学中起重要作用。有趣的是,心脏K(ATP)通道的组成成分ABCC9发生突变可导致人类扩张型心肌病,这证明心脏ABC转运蛋白功能障碍可能具有临床意义。本综述旨在深入探讨ABC转运蛋白在心脏中的可能功能、它们在药物处置中的作用,以及对细胞内环核苷酸水平的控制或K(ATP)通道电导率的调节。